NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single‐cell RNA‐seq and in vitro experiment
Weijie Ye,Xisong Liang,Ge Chen,Qiao Chen,Hao Zhang,Nan Zhang,Yuanfei Huang,Quan Cheng,Xiaoping Chen
DOI: https://doi.org/10.1111/cns.14850
2024-07-19
CNS Neuroscience & Therapeutics
Abstract:In summary, this study has revealed the role of NDC80/HEC1 in the process of glioma development and in the tumor microenvironment of glioma. The immunosuppressive property and role of HEC1 make it attractive to be used as novel prognostic biomarkers or effective therapeutic targets. Immunofluorescence of glioma tissue microarrays showed positive correlation of HEC1 expression with the malignancy degrees of glioma and a lower probability of patients with high HEC1 expression. In particular, HEC1 promotes development of glioma through the regulation of cell proliferation, cell cycle, DNA repair, and TME formation, possibly through transcriptional activation of E2F8. Moreover, tumor cells exhibiting HEC1 expression could shape the TME by interacting with macrophage and cancer‐associated fibroblasts. Coculture confirmed that glioma cells devied‐HEC1 promote macrophage migration and transform into M2. Our results provide further insight into the application of HEC1 in glioma (by Figdraw). Introduction Glioma is the most frequent and lethal form of primary brain tumor. The molecular mechanism of oncogenesis and progression of glioma still remains unclear, rendering the therapeutic effect of conventional radiotherapy, chemotherapy, and surgical resection insufficient. In this study, we sought to explore the function of HEC1 (highly expressed in cancer 1) in glioma; a component of the NDC80 complex in glioma is crucial in the regulation of kinetochore. Methods Bulk RNA and scRNA‐seq analyses were used to infer HEC1 function, and in vitro experiments validated its function. Results HEC1 overexpression was observed in glioma and was indicative of poor prognosis and malignant clinical features, which was confirmed in human glioma tissues. High HEC1 expression was correlated with more active cell cycle, DNA‐associated activities, and the formation of immunosuppressive tumor microenvironment, including interaction with immune cells, and correlated strongly with infiltrating immune cells and enhanced expression of immune checkpoints. In vitro experiments and RNA‐seq further confirmed the role of HEC1 in promoting cell proliferation, and the expression of DNA replication and repair pathways in glioma. Coculture assay confirmed that HEC1 promotes microglial migration and the transformation of M1 phenotype macrophage to M2 phenotype. Conclusion Altogether, these findings demonstrate that HEC1 may be a potential prognostic marker and an immunotherapeutic target in glioma.
pharmacology & pharmacy,neurosciences